Cingulate Inc (CING) - Volume dana dhuwit saben saham

Lambang korporat lan logo Cingulate Corp (CING)

Cingulate Inc. maintains a positive image within the ADHD therapy niche, as evidenced by the cash per share data provided in GURU.Markets, where the value 1.55 captures the metric level. The business relies on a precision drug-release system to ensure a stable effect. High scalability potential is driven by intellectual property that enables the mass production of high-cost medications for the global market.

Cingulate Inc. (CING): Dana dhuwit saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Cingulate Inc (CING)

- rega saiki lan proyeksi nilai saham:
- rincian posisi dhuwit lan arus kas:
Ringkesan analisis perusahaan:CING (Cingulate Corp)
Barang utama Cingulate

Cingulate Inc. is investing in unique CTR technology to develop ADHD medications with protection against generics. These R&D expenditures directly impact the cash balance per share. This metric measures the real value of cash reserves available to each shareholder. Sharp fluctuations in the current cash per share level signal secondary offerings or asset sales. Analyzing this chart allows for the immediate detection of investor equity dilution.